Evolent Health, Inc. - Class A Shares
Evolent Health, Inc. (EVH) is a US healthcare technology and services company focused on helping payers and providers transition to value‑based care. It combines analytics, care management platforms and operational services to support risk‑bearing contracts and population health initiatives. Investors should know Evolent generates recurring, contract-driven revenue from long-term engagements, which can provide some stability, but performance depends on successful contract execution and client retention. Key growth levers include the broader shift towards value-based reimbursement, expanded provider partnerships and technology adoption. Primary risks include regulatory or reimbursement changes, competition from larger healthcare IT firms, margin pressure if care outcomes are worse than expected, and stock volatility typical of mid-cap healthcare names. This overview is educational, not personalised investment advice; investors should evaluate financials, management commentary and sector trends, and consider seeking independent financial advice before making decisions.
Stock Performance Snapshot
Analyst Rating
Analysts highly recommend buying Evolent Health's stock with a target price of $13.23, indicating great potential for profit.
Financial Health
Evolent Health is performing well with solid revenue and cash flow, but faces challenges in profitability.
Dividend
Evolent Health's projected dividend of $0.22 results in a below average yield, making it less attractive for dividend-seeking investors. If you invested $1000 you would be paid $2.20 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring EVH
Following Buffett's Healthcare Bet
Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.
Published: August 15, 2025
Explore BasketHealthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketHealthcare In The Crosshairs: Insurers Under Scrutiny
The Department of Justice is investigating UnitedHealth Group's Medicare billing, creating uncertainty for the nation's largest insurer. This situation presents a potential opportunity for rival health insurers to gain market share and for compliance-focused companies that help the industry navigate complex regulations.
Published: July 25, 2025
Explore BasketHealthcare Billing Integrity
This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published: July 11, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Value‑based care tailwind
The shift to value‑based reimbursement can increase demand for Evolent's services, though adoption rates and reimbursement rules can vary and affect outcomes.
Technology plus services
A combined software and services model offers recurring revenue potential, but execution and contract performance remain critical to margin and growth.
Policy and payer dynamics
Regulatory, payer and market changes can materially influence results — investors should watch policy shifts and payer relationships carefully.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
